Molnupiravir

Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID‑19 in those infected by... Wikipedia

  • Pronunciation:  -peer -veer]]
  • Trade names:  Lagevrio
  • AHFS/Drugs.com:  Monograph
  • MedlinePlus:  a622027
  • data:  US DailyMed: Molnupiravir
  • Pregnancy, category:  AU: D, Not recommended
  • Routes of, administration:  By mouth
  • Legal status:  AU: S4 (Prescription only), UK: POM (Prescription only), US: ℞-only via emergency use authorization
  • CAS Number:  2349386-89-4
  • ATC code:  J05AB18 (WHO)
  • PubChem:  CID [/pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=145996610 145996610]
  • DrugBank:  DB15661
  • ChemSpider:  84400552
  • UNII:  YA84KI1VEW
  • KEGG:  D11943
  • ChEBI:  CHEBI:180653
  • ChEMBL:  CHEMBL4650320
  • Synonyms:  MK-4482, EIDD-2801
  • Data source:  DuckDuckGo